Syros Pharmaceuticals (NASDAQ:SYRS) Given Buy Rating at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 1,740,000 shares, an increase of 31.8% from the February 29th total of 1,320,000 shares. Approximately 9.6% of the shares of the stock are short sold. Based […]
StockNews.com cut shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) from a hold rating to a sell rating in a report published on Tuesday morning. Separately, Piper Sandler dropped their price objective on shares of Syros Pharmaceuticals from $11.00 to $7.00 and set an overweight rating on the stock in a research report on Tuesday, […]
Syros Pharmaceuticals, Inc (NASDAQ:SYRS) Director Acquires $3,999,998 34 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note published on Thursday morning. The brokerage issued a hold rating on the stock. A number of other brokerages have also recently commented on SYRS. JMP Securities dropped their target price on Syros Pharmaceuticals from $16.00 to $15.00 in a […]